ONCOTECH INC has a total of 31 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets measurement, biotechnology and machines are OHMX CORP, ZHENGZHOU ZHONGDAO BIOTECHNOLOGY CO LTD and IMG INST FUER MEDIZINISCHE GENOMFORSCHUNG PLANUNGSGESELLSCHAFT M B H.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | Australia | 6 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Canada | 2 | |
#6 | Iceland | 1 |
# | Industry | |
---|---|---|
#1 | Measurement | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Medical technology | |
#5 | Pharmaceuticals | |
#6 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Mechetner Eugene | 10 |
#2 | Fruehauf John | 10 |
#3 | Weisenthal Larry M | 7 |
#4 | Fruehauf John P | 7 |
#5 | Imran Mir A | 4 |
#6 | Syed Baber | 4 |
#7 | Powles Trevor J | 4 |
#8 | Spreier Russell | 4 |
#9 | Mehta Ami K | 4 |
#10 | Gandhi Deepak | 3 |
Publication | Filing date | Title |
---|---|---|
US2008280768A1 | Reagents and Methods for Predicting Drug Resistance | |
US2006160114A1 | Reagents and methods for predicting drug resistance | |
AU2003300899A8 | Genes related to sensitivity and resistance to chemotherapeutic drug treatment | |
US2003096261A1 | Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells | |
AU1465801A | Methods for cancer prognosis and diagnosis | |
US5840507A | Methods for cancer prognosis and diagnosis | |
US6008007A | Radiation resistance assay for predicting treatment response and clinical outcome | |
US5149527A | Immunopotentiating protocol for chemotherapy-responsive tumors | |
WO8906162A1 | Methods and apparatus assessing tumor resistance | |
US4996145A | Method for detecting immune-mediated cytotoxicity | |
US4735895A | Cancer susceptibility test |